Skip to content

Dexmedetomidine vs. Propofol for Cataract Surgery

Dexmedetomidine vs. Propofol for Monitored Anesthesia Care During Cataract

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00786370
Enrollment
24
Registered
2008-11-06
Start date
2008-04-30
Completion date
2010-04-30
Last updated
2012-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

propofol, dexmedetomidine, cataract, respiratory, blood pressure, Cataract surgery

Brief summary

The use of dexmedetomidine in cataract surgery is still limited and to date only one study has examined anesthetic technique in this patient population. This pilot study will therefore compare the use of dexmedetomidine and propofol in subjects undergoing cataract surgery. The primary endpoint will be based on simple cardiorespiratory measures often associated with complications from sedation as well as assessment of the achieved sedation by the attending anesthesiologist and surgeon.

Interventions

DRUGdexmedetomidine

Propofol or dexmedetomidine infusion will be started according to the randomized treatment allocation. The propofol group will receive a bolus of 2mg midazolam and 100mcg fentanyl and then continuous propofol infusion at 50-100mcg/kg/min until a Ramsay score of 3 or Bis score of 60-80 is achieved. The dexmedetomidine group will receive a bolus of dexmedetomidine 1mcg/kg for 10 minutes and then a continuous infusion of dexmedetomidine 0.2-0.7mcg/kg/hr until a Ramsay score of 3 or a Bis score of 60-80 are achieved.

DRUGPropofol

continuous propofol infusion at 50-100mcg/kg/min until a Ramsay score of 3 or Bis score of 60-80 is achieved

DRUGDexemedetomidine

continuous infusion of dexmedetomidine 0.2-0.7mcg/kg/hr until a Ramsay score of 3 or a Bis score of 60-80 are achieved.

Sponsors

The Cooper Health System
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Normal renal function 2. No chronic use of narcotics 3. ASA PS1-3 4. Males or females age 18 or older

Exclusion criteria

1. Liver disease (Child Pugh classification 1-3) 2. History of chronic use of sedatives, narcotics, alcohol or illicit drugs or allergy to any the study medications 3. History of 1st and 2nd degree heart block (not paced) 4. Any patient with EF \< 30% 5. Patients with active seizure history 6. Pregnant patients (women of child bearing potential will have a preoperative pregnancy test as is standard of practice)

Design outcomes

Primary

MeasureTime frame
To compare select cardiorespiratory effects of dexmedetomidine sedation to those of propofol sedation in patients undergoing cataract surgery.1 day

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026